{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:42:53Z","timestamp":1778539373110,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T00:00:00Z","timestamp":1500768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ctro.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T02:30:27Z","timestamp":1510713027000},"page":"79-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma \u2013 Is PSMA-PET-CT a helpful tool in radiation oncology?"],"prefix":"10.1016","volume":"7","author":[{"given":"Laila","family":"K\u00f6nig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Hauswald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Flechtenmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Kratochwil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Giesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ctro.2017.10.003_b0005","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.oraloncology.2011.04.020","article-title":"Salivary gland carcinoma in Denmark 1990\u20132005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)","volume":"47","author":"Bjorndal","year":"2011","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2017.10.003_b0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00020840-200404000-00013","article-title":"Adenoid cystic carcinoma of the head and neck: a review","volume":"12","author":"Bradley","year":"2004","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.ctro.2017.10.003_b0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.oraloncology.2006.01.001","article-title":"Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies","volume":"42","author":"Dodd","year":"2006","journal-title":"Oral Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2017.10.003_b0020","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.oraloncology.2015.04.005","article-title":"Adenoid cystic carcinoma of the head and neck\u2013An update","volume":"51","author":"Coca-Pelaz","year":"2015","journal-title":"Oral Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2017.10.003_b0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0901-5027(97)80008-2","article-title":"Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands","volume":"26","author":"Huang","year":"1997","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.ctro.2017.10.003_b0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hed.21706","article-title":"Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology","volume":"34","author":"Vander Poorten","year":"2012","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.ctro.2017.10.003_b0035","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70245-X","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review","volume":"12","author":"Laurie","year":"2011","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2017.10.003_b0040","doi-asserted-by":"crossref","first-page":"090601","DOI":"10.1118\/1.4798945","article-title":"The more important heavy charged particle radiotherapy of the future is more likely to be with heavy ions rather than protons","volume":"40","author":"Jakel","year":"2013","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.ctro.2017.10.003_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2010.01.015","article-title":"Proton vs carbon ion beams in the definitive radiation treatment of cancer patients","volume":"95","author":"Suit","year":"2010","journal-title":"Radiother Oncol"},{"issue":"17","key":"10.1016\/j.ctro.2017.10.003_b0050","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/cncr.29443","article-title":"Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival","volume":"121","author":"Jensen","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2017.10.003_b0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.radonc.2015.05.010","article-title":"High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years\u2019 experience with raster-scanned carbon ion therapy","volume":"118","author":"Jensen","year":"2016","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2017.10.003_b0060","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jcb.10661","article-title":"Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer","volume":"91","author":"Ghosh","year":"2004","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.ctro.2017.10.003_b0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","author":"Afshar-Oromieh","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.ctro.2017.10.003_b0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00259-012-2069-0","article-title":"[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH","volume":"39","author":"Afshar-Oromieh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.ctro.2017.10.003_b0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2007.02635.x","article-title":"Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique","volume":"50","author":"Mhawech-Fauceglia","year":"2007","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.ctro.2017.10.003_b0080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/modpathol.2012.66","article-title":"High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity","volume":"25","author":"Haffner","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ctro.2017.10.003_b0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2867-14-26","article-title":"Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases","volume":"14","author":"Nomura","year":"2014","journal-title":"Cancer Cell Int"},{"issue":"5","key":"10.1016\/j.ctro.2017.10.003_b0090","doi-asserted-by":"crossref","first-page":"e0125924","DOI":"10.1371\/journal.pone.0125924","article-title":"Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.ctro.2017.10.003_b0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/RLU.0000000000001220","article-title":"In Vivo visualization of prostate-specific membrane antigen in adenoid cystic carcinoma of the salivary gland","volume":"41","author":"Lutje","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.ctro.2017.10.003_b0100","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s00259-017-3737-x","article-title":"Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis","volume":"44","author":"Klein-Nulent","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630817300447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630817300447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:04:30Z","timestamp":1734566670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630817300447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"alternative-id":["S2405630817300447"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2017.10.003","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma \u2013 Is PSMA-PET-CT a helpful tool in radiation oncology?","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}